1580231000168105: bemotrizinol 17 mg / 1 g + butyl methoxydibenzoylmethane 25 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + octocrylene 20 mg / 1 g + octyl methoxycinnamate 60 mg / 1 g + titanium dioxide 42 mg / 1 g lotion, 50 mL (medicinal product pack)

• Australian concept\Australian product\medicinal product pack\bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 50 mL

Status: current, Defined. Date: 30-Nov 2021. Module: Australian Medicines Terminology module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4639151000168110	bemotrizinol 17 mg / 1 g + butyl methoxydibenzoylmethane 25 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + octocrylene 20 mg / 1 g + octyl methoxycinnamate 60 mg / 1 g + titanium dioxide 42 mg / 1 g lotion, 50 mL (medicinal product pack)	en	Fully specified name	Active	Case sensitive	Australian Medicines Terminology module
4639161000168112	bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 50 mL	en	Synonym	Active	Case sensitive	Australian Medicines Terminology module

Expanded Value Set

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product pack reference set

Back to Start